Literature DB >> 27202098

A Us Hospital Economic Impact Model for Oritavancin In Absssi Patients With Risk of Mrsa Infections.

C Wu1, K J Fortier1, K LaPensee2, W Fan2, M Mitchell2, P L Cyr1, I S Jensen1.   

Abstract

Entities:  

Year:  2014        PMID： 27202098     DOI： 10.1016/j.jval.2014.08.2108

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

Review 1.  Oritavancin: a review in acute bacterial skin and skin structure infections.

Authors:  Yahiya Y Syed; Lesley J Scott
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

2.  Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections.

Authors:  Kenneth LaPensee; Rohit Mistry; Thomas Lodise
Journal:  Am Health Drug Benefits       Date:  2019-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.